NuCana Plc (NCNA)
1.09
-0.08
(-6.84%)
USD |
NASDAQ |
Oct 02, 16:00
1.00
-0.09
(-8.26%)
After-Hours: 20:00
NuCana Net Income (Quarterly) : -4.134M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.134M |
| March 31, 2026 | -5.208M |
| December 31, 2025 | -3.305M |
| September 30, 2025 | -0.379M |
| June 30, 2025 | -32.19M |
| March 31, 2025 | -3.114M |
| December 31, 2024 | -0.8369M |
| September 30, 2024 | -5.864M |
| June 30, 2024 | -8.826M |
| March 31, 2024 | -8.670M |
| December 31, 2023 | -9.497M |
| September 30, 2023 | -8.474M |
| June 30, 2023 | -6.778M |
| March 31, 2023 | -9.559M |
| December 31, 2022 | -17.83M |
| September 30, 2022 | -5.323M |
| June 30, 2022 | -4.882M |
| Date | Value |
|---|---|
| March 31, 2022 | -11.27M |
| December 31, 2021 | -18.39M |
| September 30, 2021 | -11.08M |
| June 30, 2021 | -12.71M |
| March 31, 2021 | -13.46M |
| December 31, 2020 | -16.19M |
| September 30, 2020 | -10.84M |
| June 30, 2020 | -7.524M |
| March 31, 2020 | -5.067M |
| December 31, 2019 | -9.917M |
| September 30, 2019 | -4.779M |
| June 30, 2019 | -5.745M |
| March 31, 2019 | -6.977M |
| December 31, 2018 | -4.647M |
| September 30, 2018 | -3.279M |
| June 30, 2018 | -1.792M |
| March 31, 2018 | -8.898M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -7.018M |
| BioNTech SE | -954.35M |
| Silence Therapeutics Plc | -12.27M |
| Compass Pathways Plc | -254.25M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.134M |
| EPS Diluted (Quarterly) | -1.007 |
| Enterprise Value | -20.30M |
| Earnings Yield | -295.4% |
| Normalized Earnings Yield | -287.66 |